Home›Companies›Feel Therapeutics

Feel Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 30, 2025·Suggest an edit

About Feel Therapeutics

Feel Therapeutics is a private company based in San Francisco, California. It has reported $14,128,588 raised in two offerings on Form D since November 2019. Its chief executive is Georgios Eleftheriou.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 18, 2020Sep 2, 2020amended Apr 30, 2025$7,879,846of $9.0M target34$231KDebt, OptionsRule 506(b)Form D/A ↗2 earlier filings
Jan 28, 2019Nov 27, 2019$6,248,742fully sold13$480KEquityRule 506(b)Form D ↗
Total, two offerings$14,128,588

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Feel Therapeutics's Form D filed Apr 30, 2025.

VM
Vica Manos
Director
GE
Georgios Eleftheriou
CEO and director
CT
Charalampos Tsirmpas
Executive officer, director and promoter

Earlier filings also listed Irini Fragkiskou (executive officer, last listed Nov 2019).

Sources

  1. SECFeel Therapeutics, Inc. Form D/A, filed Jul 26, 2023
  2. SECFeel Therapeutics, Inc. Form D, filed Sep 2, 2020
  3. SECFeel Therapeutics, Inc. filing history